[LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
Homma
Y
Y
Department of Comprehensive Medicine, Tokai University School of Medicine.
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D017035:Pravastatin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013997:Time Factors; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008055:Lipids; D017035:Pravastatin